Latest blog articles

On 10 October 2022 MEP René Repasi lodged an action for annulment against the complementary taxonomy delegated regulation 2022/1214. The same regulation is also challenged by Austria, a privileged applicant under Article 263 TFEU. As a result, the General Court will in any event be required to...

Questions surrounding how the EU budget is spent or audited have been, and will always be, of interest to EU citizens. Formally, the responsibility for the implementation of the budget rests with the Commission, but it is well known that the Member States have a crucial role to play, especially in...

Although the delta variant is currently leading to a sharp increase in the number of positive Covid 19 tests, hospital admissions are fortunately still low. Let's hope it stays this way and that with the growing number of vaccinations we slowly move in the right direction with Covid 19 in Europe. If...

Over the last years, the business of influencer marketing has practically exploded. Companies have begun to realise the multiplying factor of having influencers promote their brand through original and entertaining content. However, in combination with this marketing trend, several legal issues have...

Patent aggregation is one of the critical paths to raise revenue and earn a return on investment in the ICT sector. It comprises all activities whereby firms build sets of related patents, so-called patent portfolios, and subsequently use these beyond manufacturing. Different kinds of entities...

Constructing a functioning single market for business and trade among the Member States of the European Union (EU) has been the cornerstone of the EU project, and remains one of the strongest drivers for EU-level legislative reform. Over the years, the EU has prioritized the harmonization of...

The implementation of the Unitary Patent Package will represent the result of the evolution towards the unification of the European patent system.

On 4 March 2021, Italy decided to block a shipment of the Oxford/AstraZeneca Covid-19 vaccine that was destined for Australia. This remarkable move, notably made in response to AstraZeneca’s delay in providing the agreed doses of vaccines by the set deadlines, is the first of its kind since the...

The ongoing COVID-19 pandemic is arguably one of the biggest crises of modern times. The conflict between the search for a vaccine, and the artificial scarcity created by patent law, has created a catch-22 situation. How will patent law apply to a vaccine under these circumstances?

After an exhausting few months in the ‘COVID-19 era’—as we can call it now—after months of hard work and the stress of dealing with a pandemic, everybody is looking to take a break during the summer. But unlike in recent years when we could plan our summer vacation months in advance, this year it...